Evidence Synthesis
The narrative for NUCLEUS on 2026-09-10 is as follows: NUCLEUS has accelerated its gross margin to 30.82% in the most recent quarter, up from 1.34%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 10 Sept 2026, 01:49
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
The narrative for NUCLEUS on 2026-09-10 is as follows: NUCLEUS has accelerated its gross margin to 30.82% in the most recent quarter, up from 1.34%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 30.82 % | 1.34 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 1.34 % | 12.13 | ▼ |
| REVENUE_GROWTH_YOY | -3.3 % | -32.2 | ▲ |
| EPS_ACTUAL | 9.99 INR | 13.868 | ▼ |
| EPS_SURPRISE_PERCENT | -0.316 % | -0.082 | ▼ |
| PRICE_CHANGE_PERCENT | -1.582 % | — | - |
| DAILY_VOLUME | 9,393 shares | 79,200 | ▼ |
| CLOSE_PRICE | 706.1 INR | 717.45 | ▼ |
| NEWS_SENTIMENT_SCORE | 1 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 1 | ▼ |
| TARGET_PRICE_PREMIUM | 41.62 % | — | - |